EPISODE #104 US Cannabis Legislation and Regulation in 2021 with Dr. Stuart Titus, CEO of Medical Marijuana Inc.
The Cannabis Conversation | Medical Cannabis | CBD | Hemp03/18/21 • 43 min
This week we’re joined by Dr. Stuart Titus, CEO of Medical Marijuana Inc. - developers and retailers of cannabis-derived products, and the first-ever publicly traded cannabis company in the USA.
In this episode, we explore some of the current legislation and regulations governing the cannabis industry in the USA, including the SAFE Banking Act and FDA regulation.
→ View full show notes, summary, and access resources here: https://www.canverse.global/shownotes/e104
About Dr. Stuart Titus
Dr. Stuart Titus is a veteran of the financial services and medical healthcare industries with over thirty years of combined experience in each discipline. In the investment banking industry, Dr. Titus worked with well-regarded firms including A.G. Becker, Prudential-Bache Securities, and Credit Suisse-First Boston. After leaving Wall Street, Dr. Titus opened and operated his private physiotherapy practice specialising in microcurrent and stem cell therapeutic treatments.
Now, Dr. Titus, a 10-year pioneer of the cannabis industry, is the Chief Executive Officer of the first-ever publicly traded cannabis company in the United States, Medical Marijuana, Inc. Dr. Titus has been involved in all aspects of the medical marijuana and industrial hemp industries as he also oversees a robust portfolio of subsidiary and investment companies. Through his leadership, Medical Marijuana, Inc. became the first company to deliver cannabis brands across U.S. state lines and international borders, making hemp-derived cannabidiol (CBD) available across 50 states and in dozens of countries such as Mexico, Brazil, Paraguay, Argentina and many European nations.
Dr. Titus is a graduate of Rollins College in Winter Park, Fla., where he majored in Economics and minored in Business Administration. He earned his Ph.D. degree from the Open International University, which is a World Health Organisation (WHO)-chartered affiliate. He holds a Fellowship with the American Academy of Pain Management and clinical association with the American Association of Integrative Medicine.
Quotables
- ‘My eyes were opened when all of a sudden I was introduced to the world of CBD’ 02:40
- ‘We can see CBD and the non-psychoactive arena taking a larger and larger piece of the overall cannabis pie every year 19:00
- ‘Cannabis means votes’ 29:19
Resources
Follow Medical Marijuana Inc. on Twitter: https://twitter.com/mjna_inc
Follow Medical Marijuana Inc. on LinkedIn: https://www.linkedin.com/company/medical-marijuana-inc-/
Read about the FDA’s regulation of cannabis-derived products: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#approved
03/18/21 • 43 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-cannabis-conversation-medical-cannabis-cbd-hemp-237547/episode-104-us-cannabis-legislation-and-regulation-in-2021-with-dr-stu-26467492"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to episode #104 us cannabis legislation and regulation in 2021 with dr. stuart titus, ceo of medical marijuana inc. on goodpods" style="width: 225px" /> </a>
Copy